The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tamibarotene in combination with venetoclax and azacitidine in previously untreated adult patients selected for RARA-positive AML who are ineligible for standard induction therapy (SELECT AML-1).
 
Eytan Stein
Stock and Other Ownership Interests - Auron Therapeutics
Consulting or Advisory Role - Abbvie; Agios; Aptose Biosciences; Blueprint Medicines; Bristol-Myers Squibb/Celgene; Calithera Biosciences; CTI BioPharma Corp; Daiichi Sankyo; Debiopharm Group; Foghorn Therapeutics; GEMoaB; Genentech; Genesis Pharma; Gilead Sciences; Immunogen; Janssen; Jazz Pharmaceuticals; Jnana Therapeutics; Menarini; Neoleukin Therapeutics; Novartis; OnCusp Therapeutics; Ono Pharmaceutical; Pinotbio; SERVIER; Syndax
Research Funding - agios (Inst); Bayer (Inst); BioTheryX (Inst); Bristol-Myers Squibb/Celgene (Inst); Cleave Biosciences (Inst); Eisai (Inst); Foghorn Therapeutics (Inst); Gilead Sciences (Inst); Loxo/Lilly (Inst); Prelude Therapeutics (Inst); SERVIER (Inst); Syndax (Inst); Syros Pharmaceuticals (Inst)
 
Stéphane De Botton
Honoraria - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Jazz Pharmaceuticals; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; SERVIER; Syndax
Speakers' Bureau - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Jazz Pharmaceuticals; SERVIER
Research Funding - Auron Therapeutics (Inst); Forma Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; SERVIER
 
Arnaud Pigneux
Consulting or Advisory Role - Abbvie; Agios; Bristol-Myers Squibb; Gilead Sciences; Jazz Pharmaceuticals; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Abbvie; Astellas Pharma; Gilead Sciences; Pfizer; Roche; Sanofi
Research Funding - Astellas Pharma; Roche
 
Christine McMahon
Honoraria - Abbvie; TG Therapeutics
Consulting or Advisory Role - Arcellx
Research Funding - Syros Pharmaceuticals (Inst)
 
Brian Ball
No Relationships to Disclose
 
Gautam Borthakur
Consulting or Advisory Role - Abbvie; Argenx; BiolineRx; BioTheryX; Catamaran Bio; Nkarta; Novartis; PTC Therapeutics; Takeda; Treadwell Therapeutics
Research Funding - Abbvie (Inst); Arvinas (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); BiolineRx (Inst); BioTheryX (Inst); Bristol-Myers Squibb (Inst); Cellestia Biotech (Inst); Cyclacel (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen Scientific Affairs (Inst); Lilly (Inst); MedImmune (Inst); Mundipharma Research (Inst); Nkarta (Inst); Nkarta (Inst); Novartis (Inst); Oncoceutics (Inst); PTC Therapeutics (Inst); Ryvu Therapeutics (Inst); TCR2 Therapeutics (Inst); Treadwell Therapeutics (Inst); XBiotech (Inst)
 
Alireza Eghtedar
No Relationships to Disclose
 
Suman Kambhampati
No Relationships to Disclose
 
Jason Tache
No Relationships to Disclose
 
Eunice S. Wang
Consulting or Advisory Role - Abbvie; Astellas Pharma; Celgene/Bristol-Myers Squibb; Genentech; Gilead Sciences; GlaxoSmithKline; Jazz Pharmaceuticals; Kite/Gilead; Novartis; Pfizer; Pharmaessentia; PTC Therapeutics; Stemline Therapeutics; Takeda
Speakers' Bureau - Astellas Pharma; dava oncology; Kite, a Gilead company; Pfizer; Stemline Therapeutics
 
Heather Kelley
Stock and Other Ownership Interests - Checkmate Pharmaceuticals
Consulting or Advisory Role - Acepodia; Checkmate Pharmaceuticals; Syros Pharmaceuticals
Travel, Accommodations, Expenses - Checkmate Pharmaceuticals
 
Angela Volkert
Employment - Syros Pharmaceuticals
Stock and Other Ownership Interests - Syros Pharmaceuticals
 
Kristen Baker
Employment - Syros Pharmaceuticals
Stock and Other Ownership Interests - Syros Pharmaceuticals
 
Qing Kang-Fortner
Employment - Syros Pharmaceuticals
Stock and Other Ownership Interests - Syros Pharmaceuticals
Patents, Royalties, Other Intellectual Property - I submitted a patent and owned by Syros Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Syros Pharmaceuticals
 
Catherine Madigan
Employment - Syros Pharmaceuticals
Stock and Other Ownership Interests - Alnylam; Syros Pharmaceuticals
Travel, Accommodations, Expenses - Syros Pharmaceuticals
 
Erica D. Warlick
Employment - Syros Pharmaceuticals
Stock and Other Ownership Interests - Syros Pharmaceuticals
Research Funding - Arog (Inst); Gilead Sciences (Inst); GT Biopharma (Inst)
 
David A. Roth
Employment - Syros Pharmaceuticals
Leadership - Syros Pharmaceuticals
Stock and Other Ownership Interests - Infinity Pharmaceuticals; Syros Pharmaceuticals
 
Michael Kelly
Employment - Syros Pharmaceuticals
Stock and Other Ownership Interests - Syros Pharmaceuticals
 
Daniel Aaron Pollyea
Consulting or Advisory Role - Abbvie; Agios; Amgen; Aprea Therapeutics; Astellas Pharma; Astellas Pharma; BeiGene; BerGenBio; Bristol-Myers Squibb; Celgene; Foghorn Therapeutics; Forty Seven; Genentech; Gilead Sciences; Glycomimetics; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Karyopharm Therapeutics; Kiadis Pharma; Novartis; Syndax; Syros Pharmaceuticals; Takeda
Research Funding - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Karyopharm Therapeutics (Inst); Teva (Inst)